secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K
Filed at:   2022-07-15T23:59:59+00:00
Accession:  0000944809-22-000035
Event type: litigation
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OPKO Health settles DOJ investigation for $10M; admits improper physician payments
--------------------------------------------------------------------------------

- Settlement resolves False Claims Act allegations; total payment $10M plus 1.5% annual interest from Sep 2021.
- Admits BioReference paid above-fair-market rent to physician groups from Jan 2013 to Mar 2021.
- OPKO and BioReference entered a 5-year Corporate Integrity Agreement with enhanced compliance obligations.
- Annual meeting approved all 13 director nominees, say-on-pay, and equity plan increase to 60M shares.
- Ernst & Young ratified as independent auditor for FY 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000094480922000035/0000944809-22-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000094480922000035/opk-20220714.htm
  HTML page:      https://secwatch.observer/filing/0000944809-22-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer